Bone Changes with Candidate PrEP Regimens Containing Tenofovir Disoproxil Fumarate And/or Maraviroc And/or Emtricitabine in US Men and Women: HPTN 069/ACTG A5305

˜The œjournal of antimicrobial chemotherapy/Journal of antimicrobial chemotherapy(2021)

引用 1|浏览16
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要